T1	Outcomes 875 908	VZV antibody geometric mean titer
T2	Outcomes 928 960	VZV antibody geometric mean rise
T3	Outcomes 990 1046	incidence of vaccine-related serious adverse experiences
T4	Outcomes 1213 1268	GMT ratio (refrigerated formulation/frozen formulation)
T5	Outcomes 1369 1396	vaccine-related serious AEs
T6	Outcomes 1500 1533	frequencies of injection-site AEs
T7	Outcomes 1670 1697	frequencies of systemic AEs